News
Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis
BRINSUPRI™ (brensocatib) Becomes First FDA-Approved Treatment for Bronchiectasis August 12, 2025 marks a new chapter in care for patients worldwide Tuesday, August 12, 2025, is a monumental day for the bronchiectasis community. The U.S. Food and Drug Administration...
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support
August 4th is World NTM Awareness Day: Shine a Light on Early Diagnosis and Patient Support Every year on August 4th, we come together to recognize World NTM Awareness Day, a global movement dedicated to raising awareness about nontuberculous mycobacterial (NTM)...
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference
Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference Held May 14–15 in Berkeley, California and Online The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and...
Supporting Mental Health for the NTM Community: Mental Health Awareness Month
Supporting Mental Health for the NTM Community: Mental Health Awareness Month May is Mental Health Awareness Month, a time to shine a light on the importance of emotional well-being — especially for those living with chronic illnesses like NTM (nontuberculous...
Join Us at the 2025 NTM & Bronchiectasis Patient Conference: Register Today!
We’re excited to announce that registration is now open for the 2025 NTM & Bronchiectasis Patient Conference, hosted by NTM Info & Research (NTMir)! This year’s conference promises to be an invaluable experience for patients and caregivers seeking the...
SHARE YOUR BRONCHIECTASIS STORY
Bronchiectasis patients and caregivers are urged to share their stories as soon as possible! On March 11, the Institute for Clinical and Economic Review (ICER) announced a review of brensocatib for the treatment of non-cystic fibrosis bronchiectasis (NCFB)....
The Support You Didn’t Know You Needed: Why NTM Support Groups Matter
Living with NTM lung disease (nontuberculous mycobacterial lung disease) can feel overwhelming. Between long treatment plans, frequent doctor visits, and the daily challenges of managing symptoms like coughing, fatigue, and shortness of breath, it’s easy to feel...
NTM Infection: The Overlooked Lung Disease & How to Spot It Early
Nontuberculous Mycobacteria (NTM) infections are becoming increasingly recognized as a health concern, particularly for individuals with pre-existing lung conditions. These environmental bacteria can cause chronic lung infections that may mimic other respiratory...
Surgical Treatment of Pulmonary Nontuberculous Mycobacterial Infections
Pulmonary nontuberculous mycobacterial (NTM) infections pose a significant challenge in respiratory medicine. While antibiotic therapy remains the cornerstone of treatment, surgical intervention is sometimes necessary to achieve better clinical outcomes. In this...
Travel Tips for NTM and Bronchiectasis Patients
Traveling with nontuberculous mycobacterial (NTM) lung disease or bronchiectasis might seem daunting, but with thoughtful preparation, it can be an enriching and manageable experience. By taking proactive steps to address your health needs, you can focus on...
220000
ESTIMATED CASES
OF NTM IN THE US
IN 2020
8.2 %
THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR
2.8m
ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR